Patient and control baseline characteristics
| Parameter . | Healthy controls . | All ITP . | Chronic ITP . | Acute ITP . |
|---|---|---|---|---|
| Age, y | 4-17 (12.0) | 1-17 (8.2) | 3-17 (8.2) | 1-15 (7.9) |
| Platelet count, K/μL | >150-450 | 2-104 (19) | 13-104 (52) | 2-19 (11) |
| Ig-O5 (fluorescence intensity) | 2.5-8.8 (5.3) | 7.3-10.7 (8.8) | 7.3-10.7 (8.8) | 7.5-10.3 (8.9) |
| Ig-O7 (fluorescence intensity) | 0.1-5.8 (2.3) | 2.1-9.6 (7.6) | 6.8-9.6 (8.1) | 2.1-8.5 (5.9) |
| Parameter . | Healthy controls . | All ITP . | Chronic ITP . | Acute ITP . |
|---|---|---|---|---|
| Age, y | 4-17 (12.0) | 1-17 (8.2) | 3-17 (8.2) | 1-15 (7.9) |
| Platelet count, K/μL | >150-450 | 2-104 (19) | 13-104 (52) | 2-19 (11) |
| Ig-O5 (fluorescence intensity) | 2.5-8.8 (5.3) | 7.3-10.7 (8.8) | 7.3-10.7 (8.8) | 7.5-10.3 (8.9) |
| Ig-O7 (fluorescence intensity) | 0.1-5.8 (2.3) | 2.1-9.6 (7.6) | 6.8-9.6 (8.1) | 2.1-8.5 (5.9) |
Data are presented as range (median) unless otherwise indicated.